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nave abundance and the protein levels for MMPs, respectively. 
Results: One micro mollL BNP significantly (pcO.01) enhanced zymographic gelatinase- 
A (MMP-2) abundance. In addition, protein expressions of MMP-1. -2, -3 and membra- 
nous type-l MMP were significantly increased by BNP, while MMP-9 and MMP-13 were 
unchanged. The cGMP analogue &bromo-cGMP (lo4 moliL) mimicked the BNP effect, 
whereas inhibition of protein kinase G (PKG) by KT5823 (lo* moUL) significantly 
(p-zO.05) attenuated BNP-induced zymographic MMP-2 abundance. ET-l (lo” mti) 
down-regulated the zymographic MMP-2 abundance and BNP reversed the action of ET- 
1, while TNF-alpha (lo-7 mol/L) increased BNP-induced zymographic MMP-2 abundance 
in a synergistic manner. 
Conclusions: This study reports that BNP increases MMPs via cGMP-PKG signaling. In 
addition, cross-talk between BNP and ET-l, TNF-alpha results in different biological 
effects. These findings suggest that BNP participates in the remodeling of myocardial 
structure in the progression of heart failure via the control of cardiac fibroblast function. 
2:30 pm. 
409-3 Identification of Differential Gene Expression Patterns 
in Patients With End-Stage lschemic and Noniachemic 
Cardiomyopathies 
Xinaiana Han, David Fermin. Jennifer Hall, Soon Park, Richard A. King, Leslie W. Miller, 
University of Minnesota Medical School, Minneapolis, MN 
Background: End-stage cardiomyopathy (ESCM) is associated with altered expressions 
of muitiple genes. Unloading by the left ventricular assist device (LVAD) which results in 
recovery of hemodynamic and cellular abnormalities may lead to further dynamic gene 
expression changes. 
Methods: A microarray technique representlng approximately 2l3 of known human 
genome (22283 genes, Affymetrix) was used to probe paired left ventricular samples 
from 15 patients (7 ischemic, 8 non-ischemic, on LVAD for 1 to 22 months) obtained at 
LVAD implant and transplantation; real-time polymerase chain reaction (RT-PCR) was 
used to further confirm selected gene transcript changes. 
Results: At a p value of ~0.01, at least 196 genes encompassing both cell structure pro- 
tein/matrix and subcellular signaling proteins regulating inotropy, metabolism, myocardial 
hypertrophy and apoptosis were differentially expressed between ischemlc and non- 
ischemic ESCM. In ischemlc ESCM, LVAD support resulted in increase of 68 genes and 
decrease of 81 genes. In non-lschemic ESCM, LVAD support resulted I” increase of 50 
genes and decrease of 3 genes. Five genes (Ribosomal protein L4, Heterogeneous 
nuclear ribonucleoproteln, Glycine amidinotransferase, Aquaporin 7, and KIAA0713 pro- 
tein) were found concordantly altered in both ischemic and non-ischemic ESCM. How- 
ever, these five genes responded very differently to unloading by LVAD. When patients 
were grouped by the duration of LVAD support (Month: < 2,2-10, >lO), a greater number 
of genes were found altered with longer LVAD support and the majority of genes in each 
of the three duration groups were distinct. RT-PCR experiments using specific primers 
designed for natriuretic peptide precursor B, collagen type la, four and a half LIM 
domains I, and myosin light chain 2a confirmed the microarray finding that the first two 
genes were down-regulated and the last two genes were up-regulated following LVAD. 
Conclusion: lschemic and non-ischemic ESCM are associated with dynamic and differ- 
ential expressions of different genes. Remodeling following LVAD is likely en active pro- 
cess involving activation and inactivation of different functioning groups of genes in the 
two disease entities. 
2:45 p.m. 
from spleen (DSL), 2) surveillance right ventricular endomyocardial biopsies (EMB) 
obtained at l-week and l-year after transplantation in 28-patients (age: recipient 55 f 
11.8; donor 32 *7 years) who had a paired IVUS within 4-weeks and at one year after 
transplantation for the volumetric assessment of CAV. Results: AT, mRNA expression 
in DSL (median and 25th -75th percentile: 9.9, 3.1 - 23.8 folds relative to calibrator) cor- 
related with that of EMB at l-week (1.04, 0.6 - 2.0 folds; r = 0.60, P = 0.001) and at 1-yr 
(1.5, 0.6 - 3.8 folds; r = 0.66, P = 0.0003) after transplantation. mRNA expression of AT, 
in DSL (CMIT: r=0.73. PC 0.0001; CPV: r = 0.69, P < 0.0001) and EMB at 1 -week (CMIT: 
r=O.52, F10.005;CPV: r=0.56. EO.002) and at 1-yr (CMIT: rc0.63, P < 0.0001; CPV: 
r=0.43, F10.004) aHer transplantation were univariate predictors of CAV. Multivariate 
analysis showed that mRNA expression of AT, in DLS (P= 0.01) and in l-year EMB (P= 
0.03) as significant predictors of CAV with a combined r of 0.87 and I+ of 0.75. AT, 
expression in DLS (7.4t9.8 vs 22.1+16.0 folds;F=0.004) and in EMBs at l-year (1.3 +1.6 
vs 3.le2.5 folds; P=O.Ol) were higher in recipients (n=l3) demonstrating CAV es a more 
than 0.3mm CMIT from baseline to one year. Conclusions: mRNA expression of AT, in 
DSL correlate with that of early and one-year post transplant cardiac expression. Both 
DSL and cardiac AT, expression predict accelerated progression of CAV supporting a 
potentially important role of Ang II receptor blocker in retarding its progression after 
transplantation. 
YOUNG INVESTIGATORS AWARDS COMPETITION 
409 Young Investigators Awards 
Competition: Molecular and Cellular 
Cardiology 
Monday, March 31,2003, 2:00 p.m.-3:30 p.m. 
McCormick Place, Room S104 
2:oo p.m. 
409-l Local Delivery of Culture-Modified Mononuclear Cells 
Improves Endothelial Function and Attenuates 
Neointimal Formation in a Rabbit Balloon Injury Model 
Raiiv Gulatl, Dragan Jevremovic. Timothy E. Peterson, Tyra A. Win, Laurel S. Kleppe. 
Cheryl S. Mueske, Amir Lerman, Richard G. Vile, Robert D. Simari, Mayo Clinic, 
Rochester, MN 
Background: Bone marrow derived progenitor cells have been shown to contribute to 
endothelial replacement following vascular injury. In vitro culture of peripheral blood pro- 
duces cells with phenotypic characteristics of endothelium. We hypothesized that autolo- 
gous delivery of such culture-modified mononuclear cells (CMMC) to balloon injured 
arteries could beneficially modify the vascular response to injury. 
Methods and Results: Rabbit peripheral blood mononuclear cells were cultured on 
fibronectin in endothelial growth media for 7 days yielding cells of endothelial lineage 
(CMMC). Continued culture resulted in highly proliferative outgrowth of cells with distinct 
endothelial phenotype (CD31, eNOS, acetylated LDL uptake). A rabbit model of balloon 
carotid injury was used to evaluate the effect of CMMC delivery on functional and struc- 
tural vascular responses. Animals underwent balloon injury and immediate treatment 
with autologous CMMCs or saline control by 20 minutes of local dwelling or by systemic 
ear vein injection. Fluorescent labeled CMMCs were seen to incorporate into the vessel 
wall following both routes of delivery. Local CMMC administration at the time of balloon 
inlury dramatically improved endothelial dependent vasoreactivity to acetylcholine (Ach) 
at 4 weeks compared with salme treatment (% max relaxation 77.6 +I- 6.4 vs 28.8 +I- 7 6. 
p&lt;0.005; concentration Ach [-log M] to achieve 25% mex relaxation 7.19 +/- 0.04 vs 
5.38 +/- 0.06, p&lt;O.O05). CMMC treatment also significantly reduced neointimal forma- 
tion at 4 weeks (intJmed 0.39 +I- 0.08 vs 0.86 +/- 0.17, p&lt;O.O5). 
Conclusions: These data demonstrate that delivery of CMMCs to balloon injured arteries 
is associated with markedly enhanced endothelial dependent vasoreactivity. Further- 
more, CMMCs delivered at the time of injury significantly reduce subsequent neointimal 
formation. 
2:15 pm. 
409-2 Antifibrotic Property of Brain Natriuretic Peptide in 
Cardiac Fibroblasts: Cross-Talk Action With 
Endothelin-1 and Tumor Necrosis Factor on the 
Induction of Matrix Metalloproteinases 
Toshihiro Tsuruda. Guido Boerngter, Brenda K. Huntley, Josh A. Noser, Alessendro 
Ceteliotti, John C. Burnett, Jr., Mayo Clinic. Rochester, MN 
Background: Cardiac fibroblasts (CFs) produce extracellular matrix (ECM) proteins and 
participate in the remodeling of the heart. Brain natriuretic peptide (BNP) is known to be 
activated in heart failure, and inhibit cellular proliferation; however, it is unknown if BNP 
participates in the degradation of ECM turnover. To understand the role of BNP es an 
anti-fibrotic factor in the progression of heart failure, we examined the effect of BNP and 
its signaling system on the activation of matrix metalloproteinases (MMPs), a key 
enzyme for the degradation of ECM proteins. In addition, we looked at the interactions 
between BNP and a fibrotic factor, endothekn-1 (ET-l), and a pro-inflammatory cytokine, 
TNF-alpha. 
Methods: CFs isolated from normal adult canine ventricle were used. Techniques for 
zymographic gelatlnase assay and Western bloning were employed to detect the gelati- 
409-4 Combinatorial Cytokine Gene Therapy Induces 
Synergistic lmmunosuppression and Tolerance in 
Cardiac Allograft 
Hiroshi Furukawa Kiyohiro Oshima. Hyde Russell, Thomas Tung, Jun Xu, Guanggen 
Cui, Hillel Laks, Luyi Sen, UCLA, Los Angeles, CA 
Background: Previous studies have shown that ex viva interleukrn-10 (IL-lo) gene ther- 
apy suppressed alloimmune responses and prolonged allograft surwval, but true toler- 
ance was not achieved. We assessed the hypothesis that liposome-mediated ex viva 
intracoronary Interleukin-4 (IL-4) and IL-10 comblned gene therapy may generate syner- 
gistic immunosuppression and induce allograft tolerance. 
Methods: A functional cervical heterotopic heart transplant model of rabbits was used to 
evaluate the efficiency and efficacy of the gene therapy. 
Results: The mean survival of cardiac allografl was significantly (pqO.05) prolonged from 
7*1 days in Control Group (CG) to 28a7 days in IL-IO gene therapy Group (IL-1OG) and 
135+20 days in IL-4 and IL-10 combined acne theraov Grow (IL-4&lOGI. The transaene 
and protein expression in IL-4&lOG reached the p&k in pbsioperetive’day (POD)5-8, 
and slowlv reduced thereafter. The reiection score in IL-4&lOG was sionificantlv lower 
(2.2*0.2, bc0.05) than that of CG (3.6iO.2) and IL-1OG (2.7*0.3) in POD<-6, and;.&O.O 
in POD>31. In IL-4&lOG, total graft infiltrating cells was reduced 31% in POD7-10 and 
72% in POD>31, and the percentage of CD3+ T cells was significantly decreased 
(42.7+3.4% in CG, 28.9*5.8% in IL-1OG and 20.9-tO.5% in IL-4&lOG. pcO.01) in POD7- 
10. The percentage of CD4+ T cells was significantly (pqO.01) reduced from 28.9*3.3% 
in CG to 20.9*7.2% in IL-1OG and 13.8+0.3% in IL-4BlOG in POD7-10. The reduction of 
CD&I+ T cells was even more remarkable (19.6+3.4% in CG, 14.1*3.0% in IL-IOG, 
7&0.3% in IL-4&lOG in POD7-10, pcO.01). IL-4 and IL-IO expression was correlated 
with the reduction of the graft infiltrating CD3+ T cells and CD4+/CDB+ ratio (p<O.O5), 
and inversely correlated with the rejection score (p<O.Ol). In IL-4&lOG and IL-lOG, the 
cytotoxic activity of infiltrating T cells III the allografl was greatly reduced (78+8%, and 
69+7%, respectively). 
Conclusion: The liposome-medrated ex viva intracoronary IL-4 and IL-10 combined gene 
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transfer may effectively induce the overexpression of two immunosuppressive cytokines 
simultaneously and generate synergistic immunosuppression in cardiac allograft, and 
promote the cardiac allograft tolerance. 
3:oo p.m. 
409-5 Treatment of Experimental Heart Failure With 
Hepatocyte Growth Factor 
Vasant Javasankar, Timothy J. Pirolli, Lawrence T. Bish, Mark F. Berry, Joseph Woo, Ii 
Lee Sweeney, Timothy J. Gardner, University of Pennsylvania School of Medicine, 
Philadelphia, PA 
Background: Healt failure following myocardial infarction (Ml) is a significant cause of 
morbidity and mortality and remains a difficult therapeutic challenge. Hepatocyte growth 
factor (HGF) is a potent angiogenic and anti-apoptotic protein whose receptor is upregu- 
lated following Ml. This study was designed to investigate the ability of HGF to prevent 
the develooment of heart failure in a rat model of experimental Ml. Methods: Rats under- 
went dired intramyocardial injection with replication-deficient adenovirus encoding HGF 
fn=7) or null virus es control fn=7) three weeks followina lioation of the left anterior _ 1  
descending coronary ariery. Analysis of the following was pedormed three weeks after 
InjectIon: cardiac function by pressure-volume conductance catheter measurements, LV 
wall thickness, angiogenesis by Von Willebrand’s Factor staining, and apoptosis by the 
TUNEL assay. The expression levels of HGF and the anti-apoptotic factor Bcl-2 were 
analyzed by Western blot. Results: Adeno-HGF treated animals demonstrated greater 
preservation of maximum LV pressure (HGF 77+2.9 vs Null 64i4.8 mm Hg, p=.O4), max- 
imum dP/dt (3024+266 vs 1907*360 mmtlgisec, p=.O3), maximum dV/dt (133&O vs 
84~6 plisec, p=.O4), and LV border zone wall thickness (1.98-t.06 vs 1.53k.07 mm. 
p=.OO5). Angiogenesis was enhanced (151210 vs 9Oi5 endothelial cells/hpf. p=.OO3), 
and apoptosis was reduced (3.9eO.3 vs 8.2iO.5%, p=.OO4). Increased expression of 
HGF and Bcl-2 protein was observed in the Adeno-HGF treated group. Conclusions: 
Overexpression of HGF three weeks post-MI results in enhanced angiogenesis. reduced 
apoptosis, greater preservation of ventricular geometry, and preservation of cardiac con- 
tractile function. This technique may be useful to treat or prevent post-infarction heart fail- 
ure. 
4:15 p.m. 
410-2 High-Risk Clinical Features Predict Enhanced Post- 
infarction Myocardial Apoptosis and the Need to 
Achieve Infarct-Related Artery Patency 
Antonio Abbate, Giuseppe G. Biondi-Zoccai, Rossana Bussani. Debora Camilot. 
Alessandro Petrolini, Furio Silvestri, Luigi M. Biasucci, Alfonso Baldi. Catholic University 
of Rome, Rome, Italy 
Background. Infarct-related artery (IRA) patency after AMI is associated with favorable 
LV remodeling and beneficial clinical effects, in particular in patients with high risk fea- 
tures. As it has been reported that IRA patency is associated with reduced post-infarction 
apoptotic rate (AR), aim of our study was to assess whether IRA status had a different 
impact on AR in high- vs low-risk patients. 
Methods Co-localization for TUNEL and caspase-3 was used to calculate the AR at site 
of infarction at time of death in hearts of 30 subjects who died 10 to 62 days after AMI. 
Suitable positive and negative controls were performed. The Norris coronary prognostic 
index (NI) was calculated computing age, presence of pulmonary congestion, heart size 
and history of previous additional AMI. in order to define patients’ individual risk at time of 
hospitalization. According to the NI (4 vs. >7). subjects were divided into low-risk and 
high-risk groups, since a Nl>7 carries an approximate 3-fold higher shop- and long-term 
risk of death after AMI. 
Results. Twenty subjects (67%) had persistent IRA occlusion at time of death and in 
these patients AR was significantly higher than in those with open IRA (PcO.001). How- 
ever the impact of IRA occlusion on AR was significantly different comparing high- vs 
low-risk subjects. In particular, AR was lo-fold higher in high-risk subjects with persistent 
IRA occlusion (26.1%[20.4-26.7%]) vs those with open IRA (2.3%[0.6-3.5%];P=O.O02) 
and non-significantly different in low-risk subjects with vs those without IRA occlusion 
(8.2%[2.5-17.5%] vs 5.4%[1.5-7.9%];P=0.48).Conclusion.s. In high-risk subjects, a sig- 
nificantly higher AR is associated with persistent IRA occlusion late post AMI. The 
diverse impact of IRA occlusion on AR in subjects with different nsk profile may explain 
the greater benefit obtained with coronary reperfusion in high-risk subjects, particularly 
those with LV dysfunction. The overall lower AR in low-risk subjects, however, may be 
correlated with the betler long-term prognosis after AMI in this case, independently from 
the IRA status, suggesting the need to achieve IRA patency mostly in high risk patients. 
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41 o-1 Bone Marrow Derived Cardiomyocytes Are Present in 
Adult Human Heat-l 
Ariun Deb, Shaohua Wang, Kimberly Skelding, David Simper, Noel Caplice, Mayo Clinic, 
Rochester, MN 
Background: Recent studies have identified cardiomyocytes of extracardiac origin in 
human hearts following gender mismatched cardiac transplantation but the exact source 
of these myocyte progenitors is currently unknown. 
Methods: Hearts of female patients (n=4) who had undergone gender mismatched bone 
marrow transplantation (BMT) were recovered at autopsy and analyzed for the presence 
of Y-chromosome positive cardiomyocytes. Four female patients with gender matched 
BMT served as controls. Fluorescence in situ hybridization (FISH) for Y chromosome 
was performed on paraffin embedded sections to identify cells of bone marrow origin with 
concomitant immunofluorescent labeling for a-sarcomeric actin to identify cardiomyo- 
cytes. 
Results: All patients with gender mismatched BMT were aged between 20 and 50 years 
at the time of death. The time duration from BMT to death varied between 5 weeks and 
20 months. With the exception of one patient who had sudden death, all the others died 
from complications of BMT. A total of 16000 cardiomyocyte nuclei were analyzed approx- 
imating 2000 nuclei per patient. The mean percentage of Y chromosome positive cardi- 
omyocytes in patients with sex mismatched BMT was 0.2 * 0.12% with a range of 0.1%. 
0.4%. No evidence of inflammation was found in any of the hearts studied. Not a single Y 
chromosome positive csrdiomyocyte was identified in any of the 8000 cardiomyocyte 
nuclei counted in control patients. lmmunofluorescent co-staining for basement mem- 
brane laminin and chromosomal ploidy analysis with FISH showed no evidence of either 
pseudonuclei or cell fusion in any of the chimeric cardiac myocytes identified. 
Conclusions: These data establish for the first time human bone marrow as a source of 
extra cardrac progenitor cells capable of de nova cardiomyocyte formation. The clinical 
significance of this finding will depend on further studies aimed at elucidating the mecha- 
nisms of mobilization, homing and differentiation of these cells. 
llene Claudius, Yueh-Tze Lsn. Ruey-Kang Chang, Glenn T. Wet&, Juan C. Alejos. 
University of California, Los Angeles, Los Angeles, CA 
Background: We sought to determine if B-type natriuretic peptide (BNP) levels sre pre- 
dictive of rejection or vasculopathy in children following orthotopic heart transplantation 
(OHT). BNP, an endogenous hormone produced in the ventricles, may serve as an alter- 
native to endomyocardial biopsy and angiography for detecting rejection or transplant 
coronary artery disease (TCAD) in a select group of patients. Currently, no studies exist 
evaluating the sensitivity of BNP for identifying graft pathology in children. 
Methods We conducted a retrospective review of pediatric OHT patients who under- 
went catheterization, biopsy, and echocardiogram between January and June of 2002. A 
Mann-Whitney U test was used to compare the BNP levels in patients with evidence of 
pathology and those without. Sensitivity, specificity, and predictive value of BNP to detect 
cardiac pathology were also calculated using standard statistical methods. 
Results A total of 30 patients were studied, 8 patients with evidence of either rejection 
or TCAD, either clinically or by biopsy, angiography, and echocardiogram. We found a 
significant difference (pc.01) in BNP levels between patients with evidence of pathology 
and those without. Additionally, a BNP level of greater than 100 pS/mL had a 100% sen- 
sitivity (95% Confidence Interval: 68.100%) and a 100% negative predictive value (83. 
100%) for identifying any pathology in the transplanted heart Specificity was 78% (60. 
90%) and positive predictive value 61% (36.82%). 
Conclusions BNP appears to be a highly sensitive test to identify pediatric OHT 
patients at risk for rejection or transplant coronary artery disease. 
4:45 p.m. 
410-4 Prognostic Importance of Presenting Symptoms in 
Patients Undergoing Exercise Testing for Evaluation of 
Known or Suspected Coronary Disease: A Propensity 
Analysis 
R. Christopher Jones, Claire E. Pothier, Eugene H. Blackstone, Michael S. Lauer. The 
Cleveland Clinic Foundation, Cleveland, OH 
Background: Chest symptoms, along with standard risk factors, are factored into pre- 
test risk stratification among patients who are candidates for stress testing. The indepen- 
dent pre- and post-test predictive values of symptoms are unclear. 
Methods: We studied the outcomes of 10,870 patients referred for symptom-limited 
exercise testing who had no history of myocardial revascularization, heart failure, atrial 
fibrillation, or pacemakers. Symptoms were classified according to pre-specified defini- 
tions. Propensity analysis was used to account for selection biases and baseline differ- 
ences. 
Results: Symptoms of typical angina were present in 635 patients (6%), of atypical 
angina in 3,408 (33%), of non-angina1 chest pain in 1,805 (17%). of dyspnea in 841 (a%), 
